cbdMD (YCBD) Liabilities from Discontinued Operations (2018)
cbdMD (YCBD) reported Liabilities from Discontinued Operations of 7502.0 for Q3 2018.
cbdMD (YCBD) Liabilities from Discontinued Operations (2018) Analysis & Trends
cbdMD (YCBD) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 7502.0 in Q3 2018.
- For the quarter ending Q3 2018, Liabilities from Discontinued Operations changed N/A year-over-year to 7502.0; the trailing twelve-month figure through Sep 2018 stood at 7502.0 (changed N/A YoY), and the FY2018 full-year result was 7502.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations steadied at 7502.0 in Q3 2018.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 7502.0 in Q3 2018 to a low of 7502.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 7,502.00 |
| Sep 30, 2018 | 7,502.00 |